Bivalirudin versus heparin in patients with or without bail-out GPI use: a pre-specified subgroup analysis from the BRIGHT-4 trial.
Liao J, Qiu M, Feng X, Chen K, Zhang D, Zou Y, Zheng X, Zhao G, Tian N, Zheng Z, Peng X, Yang Q, Liang Z, Li Y, Han Y, Stone GW.
Liao J, et al. Among authors: peng x.
BMC Med. 2024 Sep 27;22(1):410. doi: 10.1186/s12916-024-03579-6.
BMC Med. 2024.
PMID: 39334129
Free PMC article.
Clinical Trial.